Focused pilot

Pilot one chemical margin decision path—without hiding the evidence boundary.

A Northra pilot starts with one product family, contract pattern, and commercial question. Your team agrees the required inputs, uncertainty, human approvals, measurement method, and exit criteria before any outcome is discussed.

Prepare an enquiry Review security and data handling

A good pilot fit

A named product family, contract pattern, or account segment with a decision owner.
A traceable source signal and enough internal data to test dependency and eligibility logic.
Commercial, finance, pricing, or product experts available to review assumptions and approve actions.
A willingness to agree measurement rules, exclusions, and exit criteria before starting.

Not a good fit

A request for autonomous price changes, customer communication, or source-system write-back.
A guaranteed recovery amount, ranking outcome, or fixed pilot duration before data review.
A substitute for licensed market intelligence, ERP, BI, or a pricing execution suite.
A project without an accountable business owner or access to evidence needed to test the decision path.

Shared sequence

Scope, evidence, decision, measurement, exit.

Scope

Choose one decision path, accountable owner, evidence boundary, and success question.

Review

Agree data handling, source access, security questions, responsibilities, and exclusions.

Trace

Connect signal, dependency, contract eligibility, account exposure, and uncertainty.

Decide

Prepare a ranked, source-backed action queue for human review and approval.

Measure

Compare eligible opportunity, approved action, and outcome evidence without double counting.

Exit

Review evidence, export agreed artifacts, and follow the agreed data return or destruction path.

Required data and evidence

An approved source signal with its date, unit, currency, scope, and licence boundary.
Curated product and dependency context for the selected decision path.
The relevant signed contract version or confirmed commercial rule.
Only the volume, price, cost, and account context agreed for the measurement question.

Security review before exchange

Review source access, residency, isolation, retention, and pilot-exit requirements first.
Agree which people and systems may access each source and exported artifact.
Keep confidential values out of this public enquiry; customer-specific evidence follows the approved review path.

Open the trust center

Your team brings

A decision owner and commercial/domain reviewers.
Approved access to relevant source signals, product structure, contract rules, and account context.
Definitions for baseline, eligible opportunity, approved action, realized evidence, and exclusions.

Northra brings

A bounded workflow from source evidence to a reviewable action queue.
Visible assumptions, calculation context, uncertainty, and approval state.
An agreed evidence export and pilot-exit path; no autonomous customer action.

Measurement contract

Separate opportunity, approval, and realized evidence.

The baseline and counterfactual are agreed up front. Eligibility, overlapping actions, volume/mix effects, cost changes, and timing are recorded so the same value is not counted twice. Incomplete evidence remains incomplete; it is not promoted into a customer result.

Limitations stay visible

Missing, conflicting, or unconfirmed evidence stays unresolved; it is not replaced with a model guess.
An eligible opportunity is not a customer acceptance or a realized outcome.
Northra does not provide legal interpretation or autonomously change customer prices.

Exit criteria are agreed first

The selected question has a documented evidence trail and review decision.
Measurement states and exclusions are reconciled or clearly marked incomplete.
Agreed artifacts are exported and customer data follows the agreed return or destruction path.

Prepare the first conversation

Tell us the decision—not the confidential data.

Start with a high-level problem. Security, data residency, source access, retention, and evidence handling are reviewed before any sensitive material is exchanged.